CLINICAL OUTCOMES AFTER TWO YEARS OF A TREAT-TO-DRUG-FREE REMISSION STRATEGY WITH TOCILIZUMAB INCLUDING TREATMENT DISCONTINUATION FOLLOWING SUSTAINED REMISSION IN THE ACT-RAY STUDY (ENCORE)

Author(s):
Huizinga, T.; Conaghan, P.; Martin-Mola, E.; Schett, G.; Amital, H.; Xavier, R.; Troum, O.; Kissel, K.; Aassi, M.; Bernasconi, C.; Dougados, M.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-05-31
Language
English
Is part of
Internal Medicine Journal (2014), Vol. 44, p. 4-4
hdl
1887/103585